Interference of the antihormone RU486 in the determination of testosterone and estradiol by enzyme-immunoassay

Clinica Chimica Acta

Volumn 275, Issue 1, 1998, Pages 63-69

  Tejada, Francisco ^a   Cremades, Asunción ^a   Monserrat, Francisco ^a   Peñafiel, Rafael ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b NONE

Author keywords

Enzyme Immuno Assay; Estradiol; Hormone interference; RU486; Testosterone

Indexed keywords

ESTRADIOL; MIFEPRISTONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ERROR; DRUG DETERMINATION; ENZYME IMMUNOASSAY; ESTRADIOL BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTOSTERONE BLOOD LEVEL;

ANIMALS; CROSS REACTIONS; ESTRADIOL; FALSE POSITIVE REACTIONS; FEMALE; HORMONE ANTAGONISTS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MIFEPRISTONE; RADIOIMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; TESTOSTERONE;

ANIMALIA;

EID: 0032490533     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00077-1     Document Type: Article

References (18)

1. [1] Philibert D. RU-38486: an original multifaceted antihormone in vivo. In: Agarwal MK, editor. Adrenal steroid antagonism, Berlin, New York: Walter de Gruyter and Co, 1984: 77-98.
2. [2] Tovar A, Sánchez-Capelo A, Galindo JD, et al. Antiandrogenic effect of RU486 in the mouse kidney. Int J Biochem Cell Biol 1997;29:361-6.
3. [3] Baulieu EE. Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 1989;245:1351-7.
4. [4] Silvestre L, Dubois C, Renault M, et al. Voluntary interruption of pregnancy with mifepristone (RU486) and a prostaglandin analogue. N Engl J Med 1990;322:645-8.
5. [5] Ulmann A, Teutsch G, Philibert D. RU486. Sci Am 1990;262:42-8.
6. [6] Segal J. Mifepristone (RU486). N Engl J Med 1990;322:691-3.
7. [7] Sanchez Criado JE, Hernandez G, Bellido C, et al. Periovulatory LHRH, LH and FSH secretion in cyclic rats treated with RU486: effects of exogenous LHRH and LHRH antagonist on LH and FSH secretion at early oestrus. J Endocrinol 1994;1141:7-14.
8. [8] Szabo F, Knox KL, Ringstrom SJ, et al. Mechanism of the inhibitory action of RU486 on the secondary follicle-stimulating hormone surge. Endocrinology 1996;137:85-9.
9. [9] Knox KL, Ringstrom SJ, Szabo M, et al. RU486 on an estrogen background blocks the rise in serum follicle-stimulating hormone induced by antiserum to inhibin or ovariectomy. Endocrinology 1996;137:1226-32.
10. [10] Ringstrom SJ, Szabo M, Kilen M, et al. The antiprogestins RU486 and 2K98299 affect follicle-stimulating hormone secretion differentially on estrus but not on proestrus. Endocrinology 1997;138:2286-90.
11. [11] Sánchez-Capelo A, Cremades A, Tejada F, et al. Potassium regulates plasma testosterone and renal ornithine decarboxylase in mice. FEBS Lett 1993;333:32-4.
12. [12] Sánchez-Capelo A, Castells MT, Cremades A, et al. Hypokalemia decreases testosterone production by altering luteinizing hormone secretion. Endocrinology 1996;137:3738-43.
13. [13] Somell C, Olund A, Carlstrom K, et al. Reproductive hormones during termination of early pregnancy with mifepristone. Gynecol Obstet Invest 1990;30:224-7.
14. [14] Bakker GH, Setyono HB, Portengen H, et al. Treatment of breast cancer with different antiprogestins: preclinical and clinical studies. J Steroid Biochem Mol Biol 1990;37:789-94.
15. [15] Sánchez-Criado JE, Sanchez A, Ruiz A, et al. Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats. Acta Endocrinol Copenh 1993;129:237-45.
16. [16] Iwamasa J, Shibata S, Tanaka N, et al. The relationship between ovarian progesterone and proteolytic enzyme activity during ovulation in the gonadotropin-treated immature rats. Biol Reprod 1992;46:309-13.
17. [17] Stuenkel CA, Garzo VG, Morris S, et al. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle. Fertil Steril 1990;53:642-6.
18. [18] Lamberts SW, Koper JW, de Jong FH. The endocrine effects of long-term treatment with mifepristone (RU 486). J Clin Endocrinol Metab 1991;73:187-91.